The delivery of regenerative medicines and their impact on healthcare

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read
Not in Library

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read


Download Options

Buy this book

Last edited by LC Bot
October 23, 2011 | History

The delivery of regenerative medicines and their impact on healthcare

  • 0 Ratings
  • 0 Want to read
  • 0 Currently reading
  • 0 Have read

"Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher.

Publish Date
Publisher
CRC Press
Language
English
Pages
400

Buy this book

Previews available in: English

Edition Availability
Cover of: The delivery of regenerative medicines and their impact on healthcare

Add another edition?

Book Details


Table of Contents

(Publisher-supplied data) WHAT IS REGENERATIVE MEDICINE / Julia Polak
A NEW POLITICAL-FINANCIAL PARADIGM FOR MEDICAL RESEARCH: THE CALIFORNIA USA MODEL / Robert Klein/Alan Trounson
INVESTMENT MODELS 4. PUBLIC FUNDING IN AUSTRALIA / Graham Macdonald
CANADA: CAPITALISING ON A 50-YEAR LEGACY / Andrew Lyall
INVESTING IN REGENERATIVE MEDICINE: WHAT DRIVES THE PRIVATE INVESTOR? / Cathy Prescott
PUBLIC INVESTMENT MODELS: COMING OUT OF THE CLOSET AND GOING PUBLIC! / Reni Benjamin
CELL-BASED PRODUCTS: ALLOGENIC / Paul Kemp
AUTOLOGOUS CELL BASED PRODUCTS: FULFILLING THE PROMISE OF CELL THERAPY / Eduardo Bravo, Magdalena Blanco-Molina
BUSINESS MODELS FOR CORD BLOOD / Suzanne Watt
CHANGING THE GAME OF DRUG DISCOVERY / John Walker
DISCOVERY OF SMALL MOLECULE REGENERATIVE DRUGS / Yen Choo
THE ADOPTION OF THERAPEUTIC STEM CELL TECHNOLOGIES BY LARGE PHARMACEUTICAL COMPANIES / Alain Vertes
ROLE OF TOOLS AND TECHNOLOGIES COMPANIES IN THE SUCCESSFUL COMMERCIALIZATION OF REGENERATIVE MEDICINE / Joydeep Goswami
KEY CONSIDERATIONS IN MANUFACTURING OF CELLULAR THERAPIES / Robert Preti
STATE OF THE GLOBAL REGENERATIVE MEDICINE INDUSTRY / Lee Buckler, R. Margolin, S. Haecker
REGENERATING IP: EUROPE AFTER WARF Julian Hitchcock and Devanand Crease
PROTECTING REGENERATIVE MEDICINE INTELLECTUAL PROPERTY IN THE USE: PROBLEMS AND STRATEGIES / David Resnick, Ronald Eisenstein, Joseph McWilliams
IMPACT OF INDIAN POLICIES AND LAWS ON REGENERATIVE MEDICINE PATENT APPLICATIONS / Prabuddha Ganguli
A CATalyst FOR CHANGE: REGULATING REGENERATIVE MEDICINES IN EUROPE / Christopher Bravery
THE US REGULATORY REIMBURSEMENT POLITICAL ENVIRONMENT AND STRATEGIES FOR REFORM / Michael Werner.

Edition Notes

Includes bibliographical references and index.

Published in
Boca Raton, FL

Classifications

Dewey Decimal Class
610.28
Library of Congress
R857.T55 D45 2011

The Physical Object

Pagination
xvi, 400 p. :
Number of pages
400

ID Numbers

Open Library
OL25041424M
Internet Archive
deliveryregenera00pres_821
ISBN 13
9781439836064
LCCN
2010026460

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
October 23, 2011 Edited by LC Bot import new book
October 22, 2011 Created by LC Bot import new book